Based on this YouTube video's total view count of 173K views and industry-standard rates, the estimated total earning is $122 - $348 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Convalescent plasma, no benefit with 173,906 views, 6,516 likes, and 2,345 comments. Experience the impact of this video content that has captured audience attention.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19 15 January 2021 https://www.recoverytrial.net/news/statement-from-the-recovery-trial-chief-investigators-15-january-2021-recovery-trial-closes-recruitment-to-convalescent-plasma-treatment-for-patients-hospitalised-with-covid-19 RECOVERY trial is being conducted by the registered clinical trials units with the Nuffield Department of Population Health in partnership with the Nuffield Department of Medicine 176 hospitals across the whole of the UK Since May 2020, randomised comparison of convalescent plasma vs. usual care alone Convalescent plasma has been widely used as a treatment for COVID-19 but To date there has been no convincing evidence of the effect of convalescent plasma on clinical outcomes in patients admitted to hospital with COVID-19 On the advice of the Data Monitoring Committee (DMC), recruitment to the convalescent plasma arm of the RECOVERY trial has now closed No convincing evidence that further recruitment would provide conclusive proof of worthwhile mortality benefit Either overall or in any pre-specified subgroup N = 10,406 randomised patients Deaths, 1,873 No significant difference in the primary endpoint of 28-day mortality Convalescent plasma group (Experimental group) 18% Usual care alone group (Control group) 18% Risk ratio 1.04 (p = 0.34) Follow-up of patients is ongoing Final results will be published ASAP Recruitment to all other treatment arms – tocilizumab, aspirin, colchicine, and Regeneron’s antibody cocktail – continues as planned. Professor Martin Landray, (Oxford) Once again, the RECOVERY trial is demonstrating the value of large randomised trials to properly assess the role of potential treatments. Professor Peter Horby This is the largest ever trial of convalescent plasma and it was only possible thanks to the generous donation of plasma by recovered patients and the willingness of current patients to contribute to advancing medical care. We owe them all a great debt of gratitude Whilst the overall result is negative, we need to await the full results before we can understand whether convalescent plasma has any role in particular patient subgroups Dr Gail Miflin We await the full results with interest, there is no doubt that this trial will provide a real answer to an important question NHSBT has helped deliver the largest ever randomised control trial of convalescent plasma The story so far https://www.recoverytrial.net/news RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19 14th December 2020 Lopinavir-ritonavir is not an effective treatment for patients hospitalised with COVID-19 5th October 2020 No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY 29th June 2020 Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 16th June 2020 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 5th June 2020 Current RECOVERY trial arms Low-dose Dexamethasone (now only recruiting children) Colchicine (commonly used anti-inflammatory) Tocilizumab (an anti-inflammatory treatment given by injection) Convalescent plasma (collected from donors who have recovered from COVID-19 and contains antibodies against the SARS-CoV-2 virus) Regeneron’s antibody cocktail (a combination of monoclonal antibodies directed against coronavirus) Aspirin (commonly used to thin the blood).

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.